You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. STTR Phase I: Specialized high resolution imaging system for rapid batch screening of aflatoxin in corn

    SBC: SECURE FOOD SOLUTIONS, INCORPORATED            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be commercially deployable equipment for screening, detecting, and removing aflatoxin contaminated corn from the global food supply. Exposure to aflatoxin, a dangerous fungal carcinogen, has been linked to liver cancer, childhood stunting, illness and death in humans and animals, and majo ...

    STTR Phase I 2017 National Science Foundation
  2. STTR Phase I: Occupancy Estimation and Energy Savings with True Presence Sensors

    SBC: ADNOVIV, INC.            Topic: EW

    The broader impact/commercial potential of this project will extend to a number of applications, including smart buildings, home automation, and security. The development of this new technology for efficient indoor sensing, and development of new algorithms for occupancy sensing and counting techniques, will have immediate implications in the building automation and home construction industries, w ...

    STTR Phase I 2017 National Science Foundation
  3. STTR Phase I: Rapid Blood Cleansing Device to Combat Infection

    SBC: Path Ex, Inc.            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a dialysis-like platform for selective bacterial separation and removal from blood. This technology could potentially serve as a novel blood cleansing therapy for the treatment of disease, including sepsis. Sepsis, a life threatening organ dysfunction caused by infection, is a co ...

    STTR Phase I 2017 National Science Foundation
  4. Novel Mixed-mode TCAD-Commercial PDK Integrated Flow for Radiation Hardening By Design

    SBC: CFD Research Corporation            Topic: DTRA16A003

    Cost-effective application of advanced commercial electronics technologies in DoD space systems requires early development of radiation-hardened-by-design (RHBD) techniques, and use of simulations is critical to the efficiency of this process. CFDRC has developed an integrated, mixed-mode simulation approach allowing their NanoTCAD device physics simulator to interface with commercial circuit simu ...

    STTR Phase I 2017 Department of DefenseDefense Threat Reduction Agency
  5. STTR Phase I: Wireless point-of-care sensor for continuous fluid status monitoring of patients with congestive heart failure

    SBC: Volumetrix, LLC            Topic: SH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will provide the market with a novel non-invasive method for measuring fluid status in patients with congestive heart failure (CHF). The ability to detect volume status changes prior to the onset of heart failure symptoms has tremendous patient care and economic impact. According to the Americ ...

    STTR Phase I 2016 National Science Foundation
  6. STTR Phase I: Odorant receptor identification transforms odor design

    SBC: OdoRcept, LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be to develop odorant receptor function bioassays to provide services for companies that develop and formulate odors used in many kinds of commercial products. These services identify the biological sensors responsible for specific odor sensations and determine how these sensors are invol ...

    STTR Phase I 2016 National Science Foundation
  7. STTR Phase I: Cooperative Selection of Aptamer Pairs by Unlocking Parallel Enrichment Paths

    SBC: Proximity Biosciences LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be to develop reliable technology for the production of aptamer pairs. Aptamers are core reagents in emerging markets, regarded as alternatives to monoclonal antibodies in therapeutics, diagnostics, and imaging. They possess several appealing qualities: Ease of in vitro synthesis, flexibl ...

    STTR Phase I 2016 National Science Foundation
  8. STTR Phase I: Novel Analysis Tools for Production of Higher Indican Yielding Plants for Bio-based Indigo

    SBC: STONY CREEK COLORS, INC.            Topic: CT

    The broader impacts of this Small Business Technology Transfer Phase I project relate to the increased viability of indigo as an agricultural crop competing with synthetically manufactured indigo dye. Indigo was among the major global cash crops of the 18th and 19th centuries and accounted for 100% of the indigo dye consumed in the world. Since the beginning of the 20th century, nearly 100% of the ...

    STTR Phase I 2016 National Science Foundation
  9. STTR Phase II: A Novel Abdominal Stimulator to Assist with Ventilator Weaning in Patients

    SBC: Liberate Medical LLC            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project, in which a non-invasive respiratory muscle stimulation device and approach to weaning patients from mechanical ventilation will be developed, is a reduction in public health care expenditure and a reduction in morbidity for the half a million patients who have difficulty weaning from mechani ...

    STTR Phase II 2016 National Science Foundation
  10. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications

    SBC: GENECAPTURE            Topic: CBD15C001

    The modern warfighter faces the constant threat of endemic infections, multi-drug resistant bacteria and Biological Warfare Agents. In order to provide accurate front-line treatment that will curtail the overuse of antibiotics, a rapid and robust molecula

    STTR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government